Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-11 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-09 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |